Cargando…
Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?
OBJECTIVE: Among patients with a history of ESBL infection, uncertainty remains regarding whether all of these patients require ESBL-targeted therapy when presenting with a subsequent infection. We sought to determine the risks associated with a subsequent ESBL infection to help inform empiric antib...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031583/ https://www.ncbi.nlm.nih.gov/pubmed/36970424 http://dx.doi.org/10.1017/ash.2022.363 |
_version_ | 1784910637074219008 |
---|---|
author | Stone, Tyler J. DeWitt, Michael Johnson, James W. Beardsley, James R. Munawar, Iqra Palavecino, Elizabeth Luther, Vera P. Ohl, Christopher A. Williamson, John C. |
author_facet | Stone, Tyler J. DeWitt, Michael Johnson, James W. Beardsley, James R. Munawar, Iqra Palavecino, Elizabeth Luther, Vera P. Ohl, Christopher A. Williamson, John C. |
author_sort | Stone, Tyler J. |
collection | PubMed |
description | OBJECTIVE: Among patients with a history of ESBL infection, uncertainty remains regarding whether all of these patients require ESBL-targeted therapy when presenting with a subsequent infection. We sought to determine the risks associated with a subsequent ESBL infection to help inform empiric antibiotic decisions. METHODS: A retrospective cohort study of adult patients with positive index culture for Escherichia coli or Klebsiella pneumoniae (EC/KP) receiving medical care during 2017 was conducted. Risk assessments were performed to identify factors associated with subsequent infection caused by ESBL-producing EC/KP. RESULTS: In total, 200 patients were included in the cohort, 100 with ESBL-producing EC/KP and 100 with ESBL-negative EC/KP. Of 100 patients (50%) who developed a subsequent infection, 22 infections were ESBL-producing EC/KP, 43 were other bacteria, and 35 had no or negative cultures. Subsequent infection caused by ESBL-producing EC/KP only occurred when the index culture was also ESBL-producing (22 vs 0). Among those with ESBL-producing index culture, the incidences of subsequent infection caused by ESBL-producing EC/KP versus other bacterial subsequent infection were similar (22 vs 18; P = .428). Factors associated with subsequent infection caused by ESBL-producing EC/KP include history of ESBL-producing index culture, time ≤180 days between index culture and subsequent infection, male sex, and Charlson comorbidity index score >3. CONCLUSIONS: History of ESBL-producing EC/KP culture is associated with subsequent infection caused by ESBL-producing EC/KP, particularly within 180 days after the historical culture. Among patients presenting with infection and a history of ESBL-producing EC/KP, other factors should be considered in making empiric antibiotic decisions, and ESBL-targeted therapy may not always be warranted. |
format | Online Article Text |
id | pubmed-10031583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-100315832023-03-23 Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed? Stone, Tyler J. DeWitt, Michael Johnson, James W. Beardsley, James R. Munawar, Iqra Palavecino, Elizabeth Luther, Vera P. Ohl, Christopher A. Williamson, John C. Antimicrob Steward Healthc Epidemiol Original Article OBJECTIVE: Among patients with a history of ESBL infection, uncertainty remains regarding whether all of these patients require ESBL-targeted therapy when presenting with a subsequent infection. We sought to determine the risks associated with a subsequent ESBL infection to help inform empiric antibiotic decisions. METHODS: A retrospective cohort study of adult patients with positive index culture for Escherichia coli or Klebsiella pneumoniae (EC/KP) receiving medical care during 2017 was conducted. Risk assessments were performed to identify factors associated with subsequent infection caused by ESBL-producing EC/KP. RESULTS: In total, 200 patients were included in the cohort, 100 with ESBL-producing EC/KP and 100 with ESBL-negative EC/KP. Of 100 patients (50%) who developed a subsequent infection, 22 infections were ESBL-producing EC/KP, 43 were other bacteria, and 35 had no or negative cultures. Subsequent infection caused by ESBL-producing EC/KP only occurred when the index culture was also ESBL-producing (22 vs 0). Among those with ESBL-producing index culture, the incidences of subsequent infection caused by ESBL-producing EC/KP versus other bacterial subsequent infection were similar (22 vs 18; P = .428). Factors associated with subsequent infection caused by ESBL-producing EC/KP include history of ESBL-producing index culture, time ≤180 days between index culture and subsequent infection, male sex, and Charlson comorbidity index score >3. CONCLUSIONS: History of ESBL-producing EC/KP culture is associated with subsequent infection caused by ESBL-producing EC/KP, particularly within 180 days after the historical culture. Among patients presenting with infection and a history of ESBL-producing EC/KP, other factors should be considered in making empiric antibiotic decisions, and ESBL-targeted therapy may not always be warranted. Cambridge University Press 2023-03-08 /pmc/articles/PMC10031583/ /pubmed/36970424 http://dx.doi.org/10.1017/ash.2022.363 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
spellingShingle | Original Article Stone, Tyler J. DeWitt, Michael Johnson, James W. Beardsley, James R. Munawar, Iqra Palavecino, Elizabeth Luther, Vera P. Ohl, Christopher A. Williamson, John C. Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed? |
title | Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed? |
title_full | Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed? |
title_fullStr | Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed? |
title_full_unstemmed | Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed? |
title_short | Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed? |
title_sort | analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (esbl)–producing escherichia coli or klebsiella pneumoniae: is esbl-targeted therapy always needed? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031583/ https://www.ncbi.nlm.nih.gov/pubmed/36970424 http://dx.doi.org/10.1017/ash.2022.363 |
work_keys_str_mv | AT stonetylerj analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded AT dewittmichael analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded AT johnsonjamesw analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded AT beardsleyjamesr analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded AT munawariqra analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded AT palavecinoelizabeth analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded AT lutherverap analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded AT ohlchristophera analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded AT williamsonjohnc analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded |